Dec 26, 2022 | MedBen Rx, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs
From earlier this year: “Health plans and pharmacy benefit managers (PBMs) that manage drug costs… say specialty drugs now account for 50% or greater of the total prescription spending they manage. In some cases, employer clients are seeing specialty costs account...
Dec 22, 2022 | Lobbying, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Spending
A review of the biggest spenders in health care lobbying by OpenSecrets reveals that, in the leadup to the 2021-22 election cycle, 16 of the top 25 lobbyists were pharmaceutical & health product organizations (see table below). The top health care lobbyist,...
Dec 12, 2022 | Gene therapy, MedBen Rx, Prescription drugs, Rx Costs, Rx prices, Rx Spending
The Self-Insurer magazine recently examined the emergence of innovative gene therapies that carry substantial benefits… and hefty price tags. The FDA just approved a hemophilia B gene therapy that costs $3.5 million a dose, making it the...
Nov 12, 2022 | Biologics, MedBen Rx
From earlier this year: “The global biologics market is expected to see a 12% growth rate and reach $420.55 billion by 2025, according to a new report by The Business Research Company.” A drug therapy originating from living organisms, biologics is a...
Oct 18, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Rx Spending, Savings, White paper
Major pharmacy benefit managers (PBMs) use “smoke and mirrors” to make you believe they’re saving you money on prescription drugs: On the one hand, PBMs offer you administrative fee credits – fixed cost reductions that make up just a small...
